Ligand Pharmaceuticals LGND
$286.85 −$0.09 (-0.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $286.85 0.00%
Open$285.21
Prev close$286.94
Day range$282.36 – $291.36
Volume259.8K
Market cap$5.74B
P/E (TTM)115.2
Dividend yield–
Analyst view
ConsensusBuy
Analysts8
Average target$367.00+27.9% vs. price
- Buy 100%
Low $346.00Now $286.85Avg $367.00High $406.00
Recent rating changes
The last 20 actions on file set price targets from $345.00 to $406.00, averaging $371.59.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 12 Nov 2026 | H.C. Wainwright | BUY | $358.00 |
| 11 Nov 2026 | Barclays | BUY | $350.00 |
| 5 Nov 2026 | Citi | BUY | $402.00 |
| 1 Nov 2026 | RBC Capital | BUY | $357.00 |
| 30 Oct 2026 | BofA Securities | BUY | $406.00 |
| 30 Oct 2026 | Stifel | BUY | $350.00 |
| 30 Oct 2026 | Barclays | BUY | $345.00 |
| 30 Oct 2026 | Oppenheimer | BUY | $346.00 |
| 29 Oct 2026 | Citi | BUY | $397.00 |
| 29 Oct 2026 | H.C. Wainwright | BUY | $358.00 |
| 29 Oct 2026 | RBC Capital | BUY | $357.00 |
| 19 Oct 2026 | BofA Securities | BUY | $406.00 |
| 25 Sep 2026 | Barclays | BUY | $345.00 |
| 24 Sep 2026 | Craig-Hallum | BUY | – |
| 24 Sep 2026 | H.C. Wainwright | BUY | $358.00 |
| 23 Sep 2026 | Citi | BUY | $397.00 |
| 22 Sep 2026 | Craig-Hallum | BUY | – |
| 22 Sep 2026 | BofA Securities | BUY | $388.00 |
| 22 Sep 2026 | Stifel | BUY | – |
| 22 Sep 2026 | Citi | BUY | $397.00 |
No comments yet — be the first to weigh in on LGND.
Sign in to join the discussion.